Raws li kev txaus siab rau kev noj qab haus huv metabolic thiab kev tshawb fawb kev rog zuj zus, cov kws tshawb fawb tab tom tshawb nrhiav txoj hauv kev tshiab tshaj li kev noj qab haus huv ib txwm muaj - tswj kev kho mob xws li GLP-1 receptor agonists.
Puas yog SANA ib qho tshuaj poob phaus
Tsis yog,SANA ntsiav tshuajtam sim no tsis yog ib qho kev pom zoo tshuaj poob phaus. Txawm li cas los xij, nws yog ib qho kev sim sib xyaw hauv kev tshawb fawb, raug tshawb xyuas raws li tus neeg sib tw muaj peev xwm los kho cov rog thiab cov kab mob metabolic.
SANA (tseem hu ua MVD1; tshuaj npe: 5-(2-nitrovinyl)salicylic acid) yog nitro-olefin derivative ntawm salicylate. Cov kws tshawb fawb tau tshawb nrhiav nws lub peev xwm los cuam tshuam cov metabolism hauv lub zog-ib txoj kev sib txawv ntawm cov tshuaj noj qab haus huv-suppressing cov tshuaj poob phaus.
Yuav ua li cas cov compound txuas rau kev tshawb fawb poob phaus?
Cov kev tshawb fawb qhia tias nws tuaj yeem txhawb kev poob phaus los ntawm ntau txoj hauv kev metabolic:
Ua kom cov creatine- nyob ntawm cov thermogenesis
Qhov sib xyaw ua ke zoo li nce kev siv hluav taws xob hauv cov ntaub so ntswg adipose los ntawm kev txhawb nqa creatine -txoj kev thermogenic koom nrog.
Txhim kho mitochondrial zog metabolism
Kev tshawb fawb qhia tau hais tias nws txhim kho mitochondrial ua pa, uas yuav pab tau lub cev hlawv ntau zog.
Txhim kho cov cim metabolic
Hauv cov qauv ua ntej, qhov sib xyaw ua ke tau txo cov kev noj zaub mov zoo- ua rau muaj rog rog, txhim kho cov tshuaj insulin, thiab txo cov rog rog rog.
Thaum ntxov-kev tshawb fawb tib neeg
Kev tshawb fawb Theem 1A/B soj ntsuam soj ntsuam qhov sib xyaw ua ke ntawm kev nyab xeeb, kev zam, thiab kev tshawb nrhiav cov teebmeem metabolic (txhim kho code MVD1). Txoj kev tshawb no tau tshaj tawm txog kev txhim kho ua ntej hauv lub cev hnyav thiab cov ntshav qabzib- cov cim ntsig txog, txawm tias qhov loj dua - ntsuas kev kuaj mob tseem xav tau.
Puas yog SANA tib yam li GLP-1 cov tshuaj poob phaus
Tsis yog. SANA thiab GLP-1 cov tshuaj poob phaus tsis zoo ib yam. Txawm hais tias ob qho tib si tau tshawb fawb txog kev rog rog thiab kev noj qab haus huv metabolic, lawv ua los ntawm kev sib txawv ntawm cov kab mob lom.
SANA yog ib qho kev sim me me -molecule metabolic compound, whereas GLP-1 tshuaj (xws li semaglutide thiab tirzepatide) yog peptide-raws li tshuaj hormones uas tswj kev qab los noj mov thiab qabzib metabolism.
1. Cov chav kawm tshuaj sib txawv: SANA yog ib qho me me; GLP-1 tshuaj yog peptides.
Qhov sib txawv tseem ceeb yog lawv cov tshuaj lom neeg.
MVD1
Chav kawm: me me -kev tshawb fawb molecule
Kev faib tawm tshuaj: Nitro-olefin derivative ntawm salicylate
Cov tshuaj formula: 5-(2-nitrovinyl) salicylic acid
Kev tshawb fawb tsom: Kev siv hluav taws xob, thermogenesis, mitochondrial metabolism
SANA yog hloov kho salicylate derivative raug soj ntsuam raws li tus neeg sib tw muaj peev xwm rau kev kho mob metabolic.
GLP-1 tshuaj poob phaus
Piv txwv li: Tirzepatide
Cov peptide no-raws li cov tshuaj siv los ua cov tshuaj hormones uas tshwm sim hauv metabolic cuam tshuam nrog kev tswj kev qab los noj mov, kev tso tawm insulin, tswj ntshav qabzib, thiab ua kom lub plab zom mov.
2. Cov txheej txheem sib txawv ntawm kev ua
Yuav ua li cas GLP-1 tshuaj txhawb kev poob phaus
GLP-1 receptor agonists feem ntau tswj qab los noj mov los ntawm cov teebmeem hormonal.
Lawv cov teebmeem muaj xws li:
Txo qab los noj mov
GLP-1 signaling ua rau thaj tsam ntawm lub hlwb koom nrog kev tshaib kev nqhis thiab satiety, pab tib neeg hnov qab sai dua.
Ncua lub plab khoob
Cov zaub mov nyob hauv lub plab ntev dua, uas tuaj yeem ua rau muaj kev xav ntawm fullness.
Txhim kho glucose metabolism
GLP-1 kev ua kom muaj zog ua kom cov piam thaj-dependent insulin secretion thiab pab tswj cov ntshav qabzib. Tirzepatide ntxiv txoj hauv kev tshiab los ntawm kev ua kom lub GIP receptor, tsim kom muaj dual GLP-1 / GIP mechanism ntawm kev ua.
SANA ua haujlwm li cas
SANA zoo li ua haujlwm los ntawm lub zog- txoj kev siv nyiaj ntau dua li kev tswj hwm kev tshaib kev nqhis. Kev tshawb fawb qhia tias nws tuaj yeem ua haujlwm raws li hauv qab no:
Ua kom cov creatine- nyob ntawm cov thermogenesis
Qhov sib xyaw ua ke nce kev siv hluav taws xob hauv cov ntaub so ntswg adipose los ntawm creatine -txog thermogenic mechanism.
Txhim kho mitochondrial ua pa
Nws txhawb nqa kev ua mitochondrial, ua rau cov hlwb siv zog ntau dua.
Kev siv nyiaj metabolic ntau ntxiv
Tsis zoo li GLP-1 tshuaj, SANA tsis cuam tshuam qhov qab los noj mov; Hloov chaw, cov kws tshawb fawb tab tom tshawb nrhiav nws lub peev xwm los cuam tshuam li cas lub cev siv lub zog.
Dab tsi yog ib nrab -lub neej ntawm SANA (MVD1)
Txog rau tam sim no, qhov tseeb tshem tawm ib nrab -lub neej (t½) ntawm qhov sib txuas tsis tau tshaj tawm rau pej xeem hauv cov ntaub ntawv tshawb fawb uas twb muaj lawm. Txawm hais tias cov kev tshawb fawb soj ntsuam thaum ntxov tau soj ntsuam cov khoom siv tshuaj pharmacokinetic profile- suav nrog cov tsis muaj feem cuam tshuam rau cov ntshav plasma concentration, nqus, raug, thiab tshem tawm-lawv tsis tau tshaj tawm txog ib nrab ntawm - lub neej qhov tseem ceeb.
Hauv Phase 1A/B ua ntej-hauv- tib neeg txoj kev tshawb fawb soj ntsuam, cov kws tshawb fawb tau soj ntsuam kev nyab xeeb, kev kam rau siab, pharmacokinetics, thiab pharmacodynamics ntawm MVD1 tom qab noj ib zaug thiab ntau qhov ncauj. Txoj kev tshawb no tau soj ntsuam cov kev ntsuas tshuaj pharmacokinetic tseem ceeb, suav nrog cov ntshav siab siab tshaj plaws (Cmax), lub sijhawm rau qhov siab tshaj plaws (Tmax), thaj chaw hauv qab qhov concentration -lub sijhawm nkhaus (AUC), thiab pom meej qhov kawg tshem tawm ib nrab- lub neej. Txawm li cas los xij, cov ntaub ntawv luam tawm tsis tau muab qhov tseeb t½ tus nqi.
Cov kev tshawb fawb uas twb muaj lawm qhia tau hais tias muaj cov tshuaj pharmacokinetic ruaj khov thaum rov ua dua; plasma raug rau hnub 15 yog piv rau Hnub 1, qhia tias tsis muaj cov tshuaj tseem ceeb hauv lub sijhawm kawm.
Los ntawm qhov kev xav ntawm metabolic, nws yog qhov tseem ceeb tshwj xeeb vim tias nws txoj haujlwm lom neeg zoo li cuam tshuam nrog creatine-nyob ntawm cov thermogenesis thiab nce kev siv hluav taws xob hauv cov ntaub so ntswg adipose, tsis yog qhov qab los noj mov- tswj cov txheej txheem cuam tshuam nrog GLP-1 receptor agonists. Cov kev tshawb fawb soj ntsuam ntxiv thiab cov ncauj lus kom ntxaws pharmacokinetic tsom xam yuav tsum tau ua kom tiav cov ntsiab lus ntawm kev nqus, faib, metabolism, thiab tshem tawm.
Rau cov kws tshawb fawb thiab cov kws tshaj lij kev lag luam tshawb nrhiav cov khoom siv hauv cov kev tshawb fawb metabolic, cov ntaub ntawv txhim khu kev qha ntawm cov khoom lag luam, cov qauv zoo, cov ntaub ntawv txheeb xyuas, thiab cov khoom muaj yog ib kauj ruam tseem ceeb hauv kev npaj kev tshawb fawb.
Xi'an Sonwu muab SANA cov ntaub ntawv thiab cov ntaub ntawv txhawb nqa los pab lub chaw soj nstuam thiab cov chaw soj ntsuam lawv cov kev xav tau. Thov hu rau Xi'an Sonwu kom paub meej txog SANA capsule specifications, xeem ntawv qhia.
Email:sales@sonwu.com
Cov ntaub ntawv siv:https://www.dovepress.com/design-of-montelukast-nanocrystalline- ncua kev kawm ntawv-rau-parenteral-prolon-peer- tshuaj xyuas{{11}J1}2}full